t Matrix has decided to strengthen its expertise in the field of technological medicine by acquiring Medi Software

Technology giant Matrix has decided to strengthen its expertise in the field of technological medicine by acquiring 75% of the shares of the Israeli company Medi Software for an estimated amount of several million dollars. After the merger, the acquired company will change its name to Matrix Medika.
Medi Software specializes in providing end-to-end supervision of companies in the medical field - from characterization, engineering and development, to obtaining FDA approvals to European standardization certificates (CE). According to Matrix management (+ 2.38% 8631), the combination of Medi's activities will serve as a power multiplier for the company's extensive activities in the field of technological medicine, such as human organ printing for preoperative procedures in 3D technology (Matrix 3D), lung and respiratory disease detection using voice recognition and artificial intelligence (Matrix Defense), providing IT services to the financial and healthcare sectors in the United States (NIT) and significant involvement in the technological fight against the corona virus.
Medi Software, which has its offices in Tel Aviv, was established in 2008 by Moshe Kleiman, who serves as CEO. Kleiman will continue to manage the company, which currently employs about 30 employees who provide service to about 30 Israeli and international customers. Teva and Philips' Greenhouse), Orthospin (a company of Johnson & Johnson), Barzilai Hospital, NovaSight, Sheba Rehabilitation Institute, Clalit HMO Innovation Center, Beilinson Hospital Innovation Center, Novoxel and more.
The company has developed technological solutions for medical surgery, telemedicine, cardiology, patient rehabilitation, the worlds of aesthetics to dialysis systems and complex medical equipment. It operates in the military-security field, and markets, sells and executes projects in the field of optical tracking in Israel and abroad, mainly for the military and defense industries. The company through the digital capabilities and additional capabilities that exist in the Matrix.
The value of Matrix currently on the stock exchange is NIS 5.3 billion. In 2020, the company rolled out a revenue turnover of NIS 4 billion - about 7.2% more than in 2019. 24% of the increase was due to the merger of companies that the company acquired, including Gasttanertech and RightStar.
Motti Gutman, CEO of Matrix, said that “Matrix is ​​constantly aware of market fluctuations, customer needs and trends that characterize the industry. The medical technology industry has been accelerating in recent years, and more so against the backdrop of the corona plague. Matrix has been operating in the healthcare systems market for many years and sees it as a target market with high growth rates in the coming years.
"The acquisition of Medi Software significantly strengthens our value proposition to the medical technology market - advancing our business to improve the lives of all of us. Medi Software and company executives align with Matrix's DNA and we recognize great potential for expanding our operations through synergy and collaborations with existing Matrix activities. In the field in Israel and the United States, "he added.
Kleiman noted that "Medi Software has created and developed unique and significant capabilities in the medical world that will be strengthened and expanded in Israel and abroad. The field of medicine in general and the field of high-tech are growing at an ever-increasing rate, and at the same time their complexity is increasing. The combination of all this with the Matrix Healthcare world is a significant message for anyone interested in the medical field - from the start-up company that is making its first steps in the incubator to the innovation centers in hospitals and health funds. We strive to continue to lead and be the address for all medical development at all stages. "